Dobbins v. Social Security Administration, Commissioner

On March 13, 2026, the U.S. District Court issued a decision in Dobbins v. Commissioner of Social Security. Plaintiff John Dobbins applied for Disability Insurance Benefits, alleging severe degenerative disc disease, fibromyalgia, and major depressive disorder rendered him unable to work since 2022. An Administrative Law Judge (ALJ) denied the claim, finding Dobbins retained the residual functional capacity to perform sedentary work with limited additional restrictions. The Appeals Council denied review, making the ALJ’s decision the final agency action. Dobbins sought judicial review, arguing the ALJ improperly discounted the opinions of his treating rheumatologist and psychologist without substantial evidentiary support, and failed to properly evaluate his subjective complaints of disabling pain under the applicable pain standard. The court scrutinized the administrative record and found the ALJ’s rationale for rejecting consistent medical opinions was not adequately articulated, raising a legal error requiring remand.

The U.S. District Court reversed the Commissioner’s final decision and remanded the case to the Social Security Administration for further administrative proceedings. The court instructed the ALJ to reassess the medical opinion evidence and provide a more thorough analysis of Dobbins’s symptom allegations consistent with applicable regulations.

Whether the ALJ erred by failing to properly weigh the treating physicians’ medical opinions and by inadequately evaluating the plaintiff’s subjective pain testimony under Social Security Ruling 16-3p, thereby reaching a residual functional capacity finding not supported by substantial evidence.

The ruling reinforced the requirement that ALJs must articulate specific, legitimate reasons grounded in the record when discounting treating source opinions. It highlighted the continued judicial scrutiny over disability adjudications where subjective pain complaints are dismissed without a clear linkage to objective medical evidence and daily activity analysis, impacting how similar chronic pain and mental health cases are evaluated at the agency level.